Updates in laparoscopic surgery for perforated peptic ulcer disease: state of the art and future perspectives
Executive Summary
Perforated peptic ulcer (PUD) remains a critical global health concern, affecting approximately 4 million people annually with a perforation rate between 2% and 14%. Despite advancements in H. Pylori eradication and proton pump inhibitor (PPI) therapy, the incidence of perforated peptic ulcers (PPU) has remained constant, representing the most frequent indication for emergency gastric surgery. This briefing document synthesizes current clinical perspectives on PPU, focusing on the transition from traditional open laparotomy to laparoscopic repair.
The analysis confirms that while mortality rates are comparable between laparoscopic and open approaches, laparoscopic repair offers significant advantages in reducing postoperative pain and surgical site infections (SSI). However, successful outcomes are heavily dependent on patient selection—utilizing scoring systems like the Boey score—and the timeliness of intervention, as every hour of delay reduces the chance of survival by 2.4%. While laparoscopy is increasingly the "treatment of choice" for stable, low-risk patients, open surgery remains the gold standard for high-risk, hemodynamically unstable individuals.
Disease Overview and Epidemiology
Peptic ulcer disease (PUD) is a significant cause of hollow viscus perforation. While the overall prevalence of PUD has declined due to medical therapies, the rate of its most life-threatening complication—perforation—has not seen a corresponding reduction.
Global Impact: PUD affects 4 million people annually.
Perforation Incidence: 2–14% of PUD cases result in perforation.
Clinical Status: PPU is the second most frequent cause of hollow viscus perforation requiring urgent surgery.
Etiological Disparity:
Developing Countries: Typically affects younger males and is linked to smoking.
Developed Countries: Generally affects older, frailer patients and is linked to the use of nonsteroidal anti-inflammatory drugs (NSAIDs) or steroids.
Risk Factors: These include H. Pylori infection, smoking, physiological stress, fasting, cocaine use, and chemotherapy (specifically bevacizumab).
Clinical Presentation and Diagnostic Workup
Clinical Features
Early diagnosis of PPU is often challenging due to non-specific symptoms. However, a "typical triad" has been identified:
Sudden onset of severe abdominal pain.
Tachycardia.
Abdominal rigidity.
Additional symptoms include nausea, vomiting, and pyrexia. If gastric juice and air enter the peritoneal space, chemical peritonitis ensues. It is noted that fewer than two-thirds of patients present with frank peritonitis, which can lead to dangerous delays in diagnosis.
Diagnostic Tools
Management: The Laparoscopic Approach
Since the first laparoscopic repair in 1989, the minimal access approach has become a viable alternative to traditional laparotomy.
Patient Selection and Risk Stratification
Clinicians utilize the Boey scoring system to determine the appropriateness of a laparoscopic approach. High-risk patients (Boey score of 3) are typically steered toward open surgery.
The Boey Scoring Factors (1 point each):
Concomitant severe medical illness.
Preoperative shock (SBP <90 mmHg).
Duration of perforation >24 hours.
Morbidity and Mortality by Boey Score:
Score 0–2: Morbidity 4.7%; Mortality 0.8%.
Score 3: Morbidity 21.4%; Mortality 10.7%.
Surgical Techniques
Laparoscopic Repair: Mirrors open surgery techniques, typically involving direct suture closure with an omental pedicle plug (Cellan-Jones or Graham patch).
Sutureless Techniques: Includes gelatin sponge plugs or fibrin glue. While faster, these have not been widely adopted due to higher leak rates at the repair site.
Peritoneal Lavage: A critical step involving 2 to 10 liters of warm saline to clear debris from the quadrants.
Conversion to Open Surgery: Necessary in cases of large perforations (>6–10 mm), fragile ulcer edges, Mannheim peritonitis index >21, or extensive adhesions. Reported conversion rates vary significantly, from 4.9% to 24.5%.
Comparative Outcomes: Laparoscopic vs. Open Repair
The following table summarizes the postoperative outcomes based on meta-analyses of randomized controlled trials.
Key Findings on Complications
Mortality: No substantial statistical difference in 30-day or 90-day mortality between the two approaches.
Surgical Site Infection (SSI): Laparoscopy significantly reduces the risk of wound infection.
Leakage: While some studies show laparoscopy has a higher leak rate (roughly three times higher than open repair in some systematic reviews), this is often attributed to the "steep learning curve" and surgeon inexperience. Recent data suggest leak rates can be reduced to 2.18% as experience increases.
Hospital Stay: Laparoscopy generally results in a shorter length of stay, though these results may be biased toward younger, healthier patients (ASA I-II).
Conclusion and Future Perspectives
The current "state of the art" in PPU management suggests that laparoscopic repair is a safe and effective treatment of choice, provided the situation is appropriate. It is particularly advantageous for stable patients with small perforations (<10 mm) who present within 24 hours of symptom onset.
However, open surgery remains the primary recommendation for:
Hemodynamically unstable patients in shock.
Patients with a Boey score of 3.
Patients older than 70 years or with high ASA risk scores (III–IV).
Cases involving large pyloric ulcers (e.g., >2 cm).
Future improvements in outcomes are expected to stem from enhanced surgical training in complex gastrointestinal emergency techniques and better senior supervision in acute cases. Further multicenter randomized controlled trials are required to evaluate the efficacy of laparoscopy in elderly, frail, and high-risk subpopulations.
